Rezultaty - Steven Coutré

Redukuj rezultaty
  1. 1
    Role of envelope glycoprotein carbohydrate in human immunodeficiency virus (HIV) infectivity and virus-induced cell fusion.

    Role of envelope glycoprotein carbohydrate in human immunodeficiency virus (HIV) infectivity and virus-induced cell fusion. od Jeffrey D. Lifson, Steven Coutré, Erich Huang, E G Engleman

    Wydane 1986
    Dokumenty pełnotekstowe Dokumenty pełnotekstowe
    Artigo
    Dodaj do listy ulubionych książek
    Zapisane w:
  2. 2
    The FIP1L1-PDGFRα fusion tyrosine kinase in hypereosinophilic syndrome and chronic eosinophilic leukemia: implications for diagnosis, classification, and management

    The FIP1L1-PDGFRα fusion tyrosine kinase in hypereosinophilic syndrome and chronic eosinophilic leukemia: implications for diagnosis, classification, and management od Jason Gotlib, Jan Cools, James Malone, Stanley L. Schrier, D. Gary Gilliland, Steven Coutré

    Wydane 2003
    Dokumenty pełnotekstowe Dokumenty pełnotekstowe
    Revisão
    Dodaj do listy ulubionych książek
    Zapisane w:
  3. 3
    Ibrutinib-associated rash: a single-centre experience of clinicopathological features and management

    Ibrutinib-associated rash: a single-centre experience of clinicopathological features and management od David Iberri, Bernice Y. Kwong, Laurel A. Stevens, Steven Coutré, Jinah Kim, Jean Sabile, Ranjana H. Advani

    Wydane 2016
    Dokumenty pełnotekstowe Dokumenty pełnotekstowe
    Carta
    Dodaj do listy ulubionych książek
    Zapisane w:
  4. 4
    Cost-effectiveness of ibrutinib as first-line therapy for chronic lymphocytic leukemia in older adults without deletion 17p

    Cost-effectiveness of ibrutinib as first-line therapy for chronic lymphocytic leukemia in older adults without deletion 17p od James I. Barnes, Vasu Divi, Adrian Begaye, Russell Wong, Steven Coutré, Douglas K Owens, Jeremy D. Goldhaber‐Fiebert

    Wydane 2018
    Dokumenty pełnotekstowe
    Artigo
    Dodaj do listy ulubionych książek
    Zapisane w:
  5. 5
    Treatment advances have not improved the early death rate in acute promyelocytic leukemia

    Treatment advances have not improved the early death rate in acute promyelocytic leukemia od James Scott McClellan, Holbrook E. Kohrt, Steven Coutré, Jason Gotlib, Ravindra Majeti, Ash A. Alizadeh, Bruno C. Medeiros

    Wydane 2011
    Dokumenty pełnotekstowe Dokumenty pełnotekstowe
    Artigo
    Dodaj do listy ulubionych książek
    Zapisane w:
  6. 6
    Pilot study of the efficacy of a thrombin inhibitor for use during cardiopulmonary bypass

    Pilot study of the efficacy of a thrombin inhibitor for use during cardiopulmonary bypass od Abe DeAnda, Steven Coutré, Marc R. Moon, Conrad Vial, Linda C. Griffin, Veronica S. Law, Masashi Komeda, Lawrence Leung, D. Craig Miller

    Wydane 1994
    Dokumenty pełnotekstowe
    Artigo
    Dodaj do listy ulubionych książek
    Zapisane w:
  7. 7
    A phase 2 trial of azacitidine and gemtuzumab ozogamicin therapy in older patients with acute myeloid leukemia

    A phase 2 trial of azacitidine and gemtuzumab ozogamicin therapy in older patients with acute myeloid leukemia od Sucha Nand, Megan Othus, John E. Godwin, Cheryl L. Willman, Thomas H. Norwood, Dianna S. Howard, Steven Coutré, Harry P. Erba, Frederick R. Appelbaum

    Wydane 2013
    Dokumenty pełnotekstowe
    Artigo
    Dodaj do listy ulubionych książek
    Zapisane w:
  8. 8
    Phase I Trial of Anti-CD22 Recombinant Immunotoxin Moxetumomab Pasudotox (CAT-8015 or HA22) in Patients With Hairy Cell Leukemia

    Phase I Trial of Anti-CD22 Recombinant Immunotoxin Moxetumomab Pasudotox (CAT-8015 or HA22) in Patients With Hairy Cell Leukemia od Robert J. Kreitman, Martin S. Tallman, Tadeusz Robak, Steven Coutré, Wyndham H. Wilson, Maryalice Stetler‐Stevenson, David J. FitzGerald, Robert J. Lechleider, Ira Pastan

    Wydane 2012
    Dokumenty pełnotekstowe Dokumenty pełnotekstowe
    Artigo
    Dodaj do listy ulubionych książek
    Zapisane w:
  9. 9
    PANORAMA 2: panobinostat in combination with bortezomib and dexamethasone in patients with relapsed and bortezomib-refractory myeloma

    PANORAMA 2: panobinostat in combination with bortezomib and dexamethasone in patients with relapsed and bortezomib-refractory myeloma od Paul G. Richardson, Robert Schlossman, Melissa Alsina, Donna M. Weber, Steven Coutré, Cristina Gasparetto, Sutapa Mukhopadhyay, Michael S. Ondovik, Md Mahmudul Hasan Khan, Carole Paley, Sagar Lonial

    Wydane 2013
    Dokumenty pełnotekstowe Dokumenty pełnotekstowe
    Artigo
    Dodaj do listy ulubionych książek
    Zapisane w:
  10. 10
    A phase 2 study of ATRA, arsenic trioxide, and gemtuzumab ozogamicin in patients with high-risk APL (SWOG 0535)

    A phase 2 study of ATRA, arsenic trioxide, and gemtuzumab ozogamicin in patients with high-risk APL (SWOG 0535) od Jeffrey E. Lancet, Anna Moseley, Steven Coutré, Daniel J. DeAngelo, Megan Othus, Martin S. Tallman, Mark R. Litzow, Rami S. Komrokji, Harry P. Erba, Frederick R. Appelbaum

    Wydane 2020
    Dokumenty pełnotekstowe Dokumenty pełnotekstowe
    Artigo
    Dodaj do listy ulubionych książek
    Zapisane w:
  11. 11
    Nelarabine induces complete remissions in adults with relapsed or refractory T-lineage acute lymphoblastic leukemia or lymphoblastic lymphoma: Cancer and Leukemia Group B study 19801

    Nelarabine induces complete remissions in adults with relapsed or refractory T-lineage acute lymphoblastic leukemia or lymphoblastic lymphoma: Cancer and Leukemia Group B study 198... od Daniel J. DeAngelo, Daohai Yu, Jeffrey L. Johnson, Steven Coutré, Richard M. Stone, Alison Stopeck, Jon P. Gockerman, Beverly S. Mitchell, Frederick R. Appelbaum, Richard A. Larson

    Wydane 2007
    Dokumenty pełnotekstowe
    Artigo
    Dodaj do listy ulubionych książek
    Zapisane w:
  12. 12
    SWOG S0910: a phase 2 trial of clofarabine/cytarabine/epratuzumab for relapsed/refractory acute lymphocytic leukaemia

    SWOG S0910: a phase 2 trial of clofarabine/cytarabine/epratuzumab for relapsed/refractory acute lymphocytic leukaemia od Anjali S. Advani, Shannon McDonough, Steven Coutré, Brent L. Wood, Jerald P. Radich, Martha P. Mims, Margaret O’Donnell, S. Elkins, Michael W. Becker, Megan Othus, Frederick R. Appelbaum

    Wydane 2014
    Dokumenty pełnotekstowe Dokumenty pełnotekstowe
    Artigo
    Dodaj do listy ulubionych książek
    Zapisane w:
  13. 13
    Minimal residual hairy cell leukemia eradication with moxetumomab pasudotox: phase 1 results and long-term follow-up

    Minimal residual hairy cell leukemia eradication with moxetumomab pasudotox: phase 1 results and long-term follow-up od Robert J. Kreitman, Martin S. Tallman, Tadeusz Robak, Steven Coutré, Wyndham H. Wilson, Maryalice Stetler‐Stevenson, David J. FitzGerald, Linda Santiago, Guozhi Gao, Mark C. Lanasa, Ira Pastan

    Wydane 2018
    Dokumenty pełnotekstowe Dokumenty pełnotekstowe
    Artigo
    Dodaj do listy ulubionych książek
    Zapisane w:
  14. 14
    Human immunodeficiency virus type 1 envelope gene structure and diversity in vivo and after cocultivation in vitro

    Human immunodeficiency virus type 1 envelope gene structure and diversity in vivo and after cocultivation in vitro od Kenro Kusumi, Barbara R. Conway, Sharon C. Cunningham, Amy E. Berson, Christopher H. Evans, Astrid K. N. Iversen, Daniel C. Colvin, Michael V. Gallo, Steven Coutré, Eugene G. Shpaer

    Wydane 1992
    Dokumenty pełnotekstowe Dokumenty pełnotekstowe
    Artigo
    Dodaj do listy ulubionych książek
    Zapisane w:
  15. 15
    Tamibarotene in patients with acute promyelocytic leukaemia relapsing after treatment with all‐<i>trans</i> retinoic acid and arsenic trioxide

    Tamibarotene in patients with acute promyelocytic leukaemia relapsing after treatment with all‐<i>trans</i> retinoic acid and arsenic trioxide od David Sanford, Francesco Lo‐Coco, Miguel Á. Sanz, Eros Di Bona, Steven Coutré, Jessica K. Altman, Meir Wetzler, Steven L. Allen, Farhad Ravandi, Hagop M. Kantarjian, Jorge E. Cortés

    Wydane 2015
    Dokumenty pełnotekstowe
    Artigo
    Dodaj do listy ulubionych książek
    Zapisane w:
  16. 16
    Sequential azacitidine plus lenalidomide combination for elderly patients with untreated acute myeloid leukemia

    Sequential azacitidine plus lenalidomide combination for elderly patients with untreated acute myeloid leukemia od Daniel A. Pollyea, James L. Zehnder, Steven Coutré, Jason Gotlib, Leonel Gallegos, Omar Abdel‐Wahab, Peter L. Greenberg, Bing Zhang, Michaela Liedtke, Caroline Berube, Ross L. Levine, Beverly S. Mitchell, Bruno C. Medeiros

    Wydane 2012
    Dokumenty pełnotekstowe Dokumenty pełnotekstowe
    Artigo
    Dodaj do listy ulubionych książek
    Zapisane w:
  17. 17
    Southwest Oncology Group Study S0530: a phase 2 trial of clofarabine and cytarabine for relapsed or refractory acute lymphocytic leukaemia

    Southwest Oncology Group Study S0530: a phase 2 trial of clofarabine and cytarabine for relapsed or refractory acute lymphocytic leukaemia od Anjali S. Advani, Holly Gundacker, Olga Sala‐Torra, Jerald P. Radich, Raymond Lai, Marilyn L. Slovak, Jeffrey E. Lancet, Steven Coutré, Robert K. Stuart, Martha P. Mims, Patrick J. Stiff, Frederick R. Appelbaum

    Wydane 2010
    Dokumenty pełnotekstowe Dokumenty pełnotekstowe
    Artigo
    Dodaj do listy ulubionych książek
    Zapisane w:
  18. 18
    Phase I and Pharmacologic Study of SNS-032, a Potent and Selective Cdk2, 7, and 9 Inhibitor, in Patients With Advanced Chronic Lymphocytic Leukemia and Multiple Myeloma

    Phase I and Pharmacologic Study of SNS-032, a Potent and Selective Cdk2, 7, and 9 Inhibitor, in Patients With Advanced Chronic Lymphocytic Leukemia and Multiple Myeloma od Wei-Gang Tong, Rong Chen, William Plunkett, David S. Siegel, Rajni Sinha, R. Donald Harvey, Ashraf Badros, Leslie Popplewell, Steven Coutré, Judith A. Fox, Kristi Mahadocon, Tianling Chen, Peggy Kegley, Ute Hoch, William G. Wierda

    Wydane 2010
    Dokumenty pełnotekstowe
    Artigo
    Dodaj do listy ulubionych książek
    Zapisane w:
  19. 19
    Venetoclax for patients with chronic lymphocytic leukemia who progressed during or after idelalisib therapy

    Venetoclax for patients with chronic lymphocytic leukemia who progressed during or after idelalisib therapy od Steven Coutré, Michael Y. Choi, Richard R. Furman, Herbert Eradat, Leonard T. Heffner, Jeffrey A. Jones, Brenda Chyla, Lang Zhou, Suresh Agarwal, Tina Waskiewicz, Maria Verdugo, Rod Humerickhouse, Jalaja Potluri, William G. Wierda, Matthew S. Davids

    Wydane 2018
    Dokumenty pełnotekstowe Dokumenty pełnotekstowe
    Artigo
    Dodaj do listy ulubionych książek
    Zapisane w:
  20. 20
    A phase 1 study of the PI3Kδ inhibitor idelalisib in patients with relapsed/refractory mantle cell lymphoma (MCL)

    A phase 1 study of the PI3Kδ inhibitor idelalisib in patients with relapsed/refractory mantle cell lymphoma (MCL) od Brad S. Kahl, Stephen E. Spurgeon, Richard R. Furman, Ian W. Flinn, Steven Coutré, Jennifer R. Brown, Don M. Benson, John C. Byrd, Sissy Peterman, Yoonjin Cho, Albert S. Yu, Wayne R. Godfrey, Nina D. Wagner‐Johnston

    Wydane 2014
    Dokumenty pełnotekstowe Dokumenty pełnotekstowe
    Artigo
    Dodaj do listy ulubionych książek
    Zapisane w:

Narzędzie wyszukiwania: